The HES algorithm (which combines AFP levels, AFP rate of change, age, alanine aminotransferase levels, and platelet count) has been found to improve the statistical performance of AFP alone in monitoring HCC but underestimate the risk of HCC observed in the next 6 months [87]. This evidence concerns the gene GPT and hepatocellular carcinoma.